Status:
COMPLETED
Study of Complementary Therapies in Men Receiving Radiation Therapy for Prostate Cancer: A Feasibility Trial
Lead Sponsor:
Brigham and Women's Hospital
Conditions:
Prostate Cancer
Eligibility:
MALE
30+ years
Phase:
NA
Brief Summary
Randomized clinical study of two CAM therapies, 1) Reiki and 2) Relaxation Response Therapy with Cognitive Restructuring counseling (RRT with CR), compared to an education-only control arm in patients...
Detailed Description
Part of the mission of the Dana-Farber/Brigham and Women's Cancer Center is to enhance the quality of life for cancer patients and their families. Treatments and therapies specifically designed to add...
Eligibility Criteria
Inclusion
- Age \> 30
- Histologic documentation of prostate cancer (no time limit)
- Gleason score assignment is mandatory prior to entry
- ECOG Performance Status of 0, 1, or 2
- Clinical Stage Tl - T4 adenocarcinoma of the prostate
- Planned androgen suppression therapy prior to an eight-week course of external beam radiotherapy
- Signed Informed Consent
Exclusion
- Prior pelvic radiotherapy
- Evidence of metastatic disease
- Currently receiving ongoing psychotherapy or antidepressive medications
- Non-English speaking
Key Trial Info
Start Date :
March 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 15 2017
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT00207259
Start Date
March 1 2005
End Date
June 15 2017
Last Update
July 13 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Brigham and Women's Hospital
Boston, Massachusetts, United States, 02115